These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 5397691

  • 1. [Growth of transplantable mammary carcinoma in mice: dependence on ovarian hormones for enhancing effect of growth hormone and prolactin].
    Speiser T, Laron Z, Gitter S.
    Harefuah; 1969 Nov 02; 77(9):381-4. PubMed ID: 5397691
    [No Abstract] [Full Text] [Related]

  • 2. Organ cultures of mouse mammary tumors in various hormonal environments: an ultrastructural study.
    Michelson SF, Haguenau F.
    J Natl Cancer Inst; 1969 Apr 02; 42(4):545-58. PubMed ID: 5775807
    [No Abstract] [Full Text] [Related]

  • 3. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
    Geradts J, Richards J, Edery M, Pang K, Larson L, Nandi S.
    Cancer Res; 1986 Apr 02; 46(4 Pt 2):1920-7. PubMed ID: 3004710
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors.
    Nandi S, Haslam S, Helmich C.
    J Natl Cancer Inst; 1972 Apr 02; 48(4):1005-12. PubMed ID: 4336864
    [No Abstract] [Full Text] [Related]

  • 5. Response of beagle mammary dysplasias to various hormone supplements in vitro.
    Warner MR.
    Cancer Res; 1977 Jul 02; 37(7 Pt 1):2062-7. PubMed ID: 861935
    [No Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone and prolactin on mouse transplantable mammary adenocarcinoma.
    Speiser Z, Gitter S, Laron Z.
    Experientia; 1966 Aug 15; 22(8):523-4. PubMed ID: 5968627
    [No Abstract] [Full Text] [Related]

  • 7. Role of ovarian hormones in the growth of transplantable mammary carcinoma.
    Murota SI, Hollander VP.
    Endocrinology; 1971 Aug 15; 89(2):560-4. PubMed ID: 5558003
    [No Abstract] [Full Text] [Related]

  • 8. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ.
    J Natl Cancer Inst; 1966 Feb 15; 36(2):289-97. PubMed ID: 4286277
    [No Abstract] [Full Text] [Related]

  • 9. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
    Matsuzawa A, Kaneko T, Ikeda Y.
    Cancer Res; 1983 May 15; 43(5):2283-9. PubMed ID: 6831452
    [Abstract] [Full Text] [Related]

  • 10. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
    Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Törnell J.
    J Clin Invest; 1997 Dec 01; 100(11):2744-51. PubMed ID: 9389738
    [Abstract] [Full Text] [Related]

  • 11. The effect of perphenazine-induced serum prolactin response on estrogen-primed mammary tumor-host systems, 13762 and R-35 mammary adenocarcinomas.
    Bogden AE, Taylor DJ, Kuo EY, Mason MM, Speropoulos A.
    Cancer Res; 1974 Nov 01; 34(11):3018-25. PubMed ID: 4419558
    [No Abstract] [Full Text] [Related]

  • 12. The effects of interstitial cell-stimulating hormone, prolactin, and bovine growth hormone on the transplantable Leydig cell tumor in the mouse.
    Yang WH, Jones AL, Li CH.
    Cancer Res; 1974 Oct 01; 34(10):2440-50. PubMed ID: 4416238
    [No Abstract] [Full Text] [Related]

  • 13. Strain differences in response of the mouse mammary gland to hormones in vitro.
    Singh DV, DeOme KB, Bern HA.
    J Natl Cancer Inst; 1970 Oct 01; 45(4):657-75. PubMed ID: 5513496
    [No Abstract] [Full Text] [Related]

  • 14. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW, Aylsworth CF, Meites J.
    Cancer Res; 1981 Apr 01; 41(4):1384-8. PubMed ID: 6783295
    [Abstract] [Full Text] [Related]

  • 15. A transplantable pregnancy-dependent mammary tumor line (TPDMT-4) in strain DDD mice.
    Matsuzawa A, Yamamoto T.
    Gan; 1974 Aug 01; 65(4):307-15. PubMed ID: 4426477
    [No Abstract] [Full Text] [Related]

  • 16. Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.
    Arafah BM, Griffin P, Gordon NH, Pearson OH.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5605-8. PubMed ID: 6498820
    [Abstract] [Full Text] [Related]

  • 17. Biological and morphological characteristics of mammary tumors in GR mice.
    van Nie R, Dux A.
    J Natl Cancer Inst; 1971 Apr 01; 46(4):885-97. PubMed ID: 5573773
    [No Abstract] [Full Text] [Related]

  • 18. Site-selective growth of a hormone-responsive human breast carcinoma in athymic mice.
    White AC, Levy JA, McGrath CM.
    Cancer Res; 1982 Mar 01; 42(3):906-12. PubMed ID: 7059989
    [Abstract] [Full Text] [Related]

  • 19. Effects of estradiol and prolactin on growth of rat mammary adenocarcinoma cells in monolayer cultures.
    Chan PC, Tsuang J, Head J, Cohen LA, Weisburger JH.
    Proc Soc Exp Biol Med; 1976 Feb 01; 151(2):362-5. PubMed ID: 943106
    [Abstract] [Full Text] [Related]

  • 20. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
    Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND.
    Oncogene; 2000 Feb 21; 19(8):1077-84. PubMed ID: 10713693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.